Sheth K, Garza E, Saju A, Nazir N, Agarwal A
What is retatrutide and why does injection technique matter Retatrutide (LY3437943) is a triple-hormone-receptor agonist developed by Eli Lilly
One randomized, double-blind, placebo-controlled study found that consuming 10 grams of a soluble vegetable fiber called Fibersol with a meal, increased levels of GLP-1 and hunger hormone PYY significantly compared to the placebo group
Topical BPC-157 formulations have shown effectiveness in research settings
With obesity linked to hypertension, dyslipidemia, sleep apnea, cardiovascular disease, fatty liver disease, and kidney complications, GLP-1 drugs have become platform therapies rather than single-indication products